会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Abdominal and hamstring muscle strength conditioning device
    • 腹肌和腿筋肌力调理装置
    • US20050107225A1
    • 2005-05-19
    • US10946923
    • 2004-09-22
    • Jack Diamond
    • Jack Diamond
    • A63B21/065A63B23/02
    • A63B23/0211A63B21/4025
    • A strength conditioning device for strengthening and conditioning abdominal and hamstring muscles is provided. The device includes at least one flex member, a seat, an ankle support attachment member and an ankle support frame. Each flex member has a first end portion, a second end portion and a middle portion between the first and second end portions, each middle portion having a curved region. The seat has an upper surface for receiving the buttocks and/or upper posterior thigh portions of a user and is attached to the second end portions of the flex members. The ankle support attachment member is attached to the first end portions of the flex members. The ankle support frame, which is attached to the ankle support attachment member, has left and right ankle support members oppositely positioned on either side of the flex members for supporting the ankles of the user. The device may further include a forefoot bar, attached to the ankle support frame, and configured to support the user's forefeet.
    • 提供了一种用于加强和调节腹部和腿筋肌肉的强度调节装置。 该装置包括至少一个挠曲构件,座椅,脚踝支撑附接构件和脚踝支撑框架。 每个柔性构件具有在第一和第二端部之间的第一端部,第二端部和中间部分,每个中间部分具有弯曲区域。 座椅具有用于接收使用者的臀部和/或上后大腿部分的上表面,并且附接到柔性构件的第二端部。 脚踝支撑附接构件附接到柔性构件的第一端部。 附接到脚踝支撑附接构件的脚踝支撑框架具有相对地位于柔性构件的任一侧的左脚踝支撑构件和右踝支撑构件,用于支撑使用者的脚踝。 该装置还可以包括附接到脚踝支撑框架并且被配置为支撑使用者的前脚掌的前足杆。
    • 3. 发明授权
    • Abdominal and hamstring muscle strength conditioning device
    • 腹肌和腿筋肌力调理装置
    • US07407467B2
    • 2008-08-05
    • US10946923
    • 2004-09-22
    • Jack Diamond, Jr.
    • Jack Diamond, Jr.
    • A63B21/00
    • A63B23/0211A63B21/4025
    • A strength conditioning device for strengthening and conditioning abdominal and hamstring muscles is provided. The device includes at least one flex member, a seat, an ankle support attachment member and an ankle support frame. Each flex member has a first end portion, a second end portion and a middle portion between the first and second end portions, each middle portion having a curved region. The seat has an upper surface for receiving the buttocks and/or upper posterior thigh portions of a user and is attached to the second end portions of the flex members. The ankle support attachment member is attached to the first end portions of the flex members. The ankle support frame, which is attached to the ankle support attachment member, has left and right ankle support members oppositely positioned on either side of the flex members for supporting the ankles of the user. The device may further include a forefoot bar, attached to the ankle support frame, and configured to support the user's forefeet.
    • 提供了一种用于加强和调节腹部和腿筋肌肉的强度调节装置。 该装置包括至少一个挠曲构件,座椅,脚踝支撑附接构件和脚踝支撑框架。 每个柔性构件具有在第一和第二端部之间的第一端部,第二端部和中间部分,每个中间部分具有弯曲区域。 座椅具有用于接收使用者的臀部和/或上后大腿部分的上表面,并且附接到柔性构件的第二端部。 脚踝支撑附接构件附接到柔性构件的第一端部。 附接到脚踝支撑附接构件的脚踝支撑框架具有相对地位于柔性构件的任一侧的左脚踝支撑构件和右踝支撑构件,用于支撑使用者的脚踝。 该装置还可以包括附接到脚踝支撑框架并且被配置为支撑使用者的前脚掌的前足杆。
    • 6. 发明授权
    • Methods for treatment of drug-induced peripheral neuropathy
    • 治疗药物性周围神经病变的方法
    • US06630478B2
    • 2003-10-07
    • US09899901
    • 2001-07-06
    • Jack DiamondAlvin J. GlaskyMark M. Foreman
    • Jack DiamondAlvin J. GlaskyMark M. Foreman
    • A61K3152
    • C07D473/18A61K31/404A61K31/505A61K31/513A61K31/52A61K31/522C07D473/30Y02A50/401
    • A method of treating drug-induced peripheral neuropathy comprising administering to a patient with drug-induced peripheral neuropathy an effective quantity of N-4-carboxaphenyl-3-(6-oxohydropurin-9-yl)propananide AIT-082, is disclosed. Peripheral nerve sprouting can be induced through the action of a neurotrophic factor such as nerve growth factor (NGF) without the occurrence of hyperalgesia. The peripheral nerve sprouting can be nociceptive nerve sprouting. The drug-induced peripheral neuropathy is associated with the administration of oncolytic drugs, such as a vinca alkaloid, cisplatin, paclitaxel, suramin, altretamine, carboplatin, chlorambucil, cytarabine, dacarbazine, docetaxel, etoposide, fludarabine, ifosfamide with mesna, tamoxifen, teniposide, or thioguanine.
    • 一种治疗药物诱发的周围神经病变的方法,其包括给予患有药物诱导的周围神经病变的患者有效量的N-4-羧基苯基-3-(6-氧代氢嘌呤-9-基)丙脒AIT-082。 可通过神经营养因子如神经生长因子(NGF)的作用诱导外周神经发芽,而不发生痛觉过敏。 外周神经发芽可引起伤害性神经发芽。 药物诱导的周围神经病变与溶瘤药物如长春花生物碱,顺铂,紫杉醇,苏拉明,高乐丹,卡铂,苯丁酸氮芥,阿糖胞苷,达卡巴嗪,多西他赛,依托泊苷,氟达拉滨,异环磷酰胺与美沙司,他莫昔芬,替尼泊苷 ,或硫鸟嘌呤。